Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson’s Patients, Using In Vivo 31P MRS-Based Metabolic Imaging at 7T is a research paper published in Metabolites (2021). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 MH111413, R01 CA240953, R01 NS118330, U01 EB026978, P41 EB027061, P30 NS076408
University of Minnesota
Grant: Academic Health Center Faculty Research Development Grant
University of Minnesota Foundation
Grant: N/A
National Institutes of Health
Grant: 5R01MH111413-02
Integrated fMRI Methods to Study Neurophysiology and Circuit Dynamics at Laminar and Columnar Level
National Institutes of Health
Grant: 3P41EB027061-03S1
Technology to Realize the Full Potential of UHF MRI (Supplement)
National Institutes of Health
Grant: 5R01NS118330-02
Advancing simultaneous fMRI-multiphoton imaging technique to study brain function and connectivity across different scales at ultrahigh field
National Institutes of Health
Grant: 5R01CA240953-03
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
National Institutes of Health
Grant: 5P30NS076408-09
Institutional Center Cores for Advanced Neuroimaging
National Institutes of Health
Grant: 5U01EB026978-03
Breaking Spatiotemporal Barriers of MR Imaging Technologies to Study Human Brain Function and Neuroenergetics
FWCI
2.41
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials
Additional file 1 of Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials
Additional file 1 of Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials